» Articles » PMID: 36382010

Clinical Perspectives on the Menstrual Pictogram for the Assessment of Heavy Menstrual Bleeding

Overview
Journal Hum Reprod Open
Date 2022 Nov 16
PMID 36382010
Authors
Affiliations
Soon will be listed here.
Abstract

Heavy menstrual bleeding (HMB) has an estimated prevalence of 18-32% but is known to be under-reported due to poor recognition and estimation of menstrual blood loss (MBL). HMB can negatively impact quality of life, affecting social interactions, work productivity and sexual life. Abnormal menstrual bleeding may have an underlying structural or systemic cause, such as endometrial and myometrial disorders; however, for some, there is no identified pathological cause. Several methods are available for assessing MBL, including the alkaline hematin (AH) method and the menstrual pictogram (MP). The AH method is considered to be the most accurate way to monitor MBL; however, it is associated with inconvenience and expense, therefore limiting its value outside of research. The MP requires the user to select an icon from a chart that reflects the appearance of a used sanitary product; the icon is associated with a blood volume that can be used to determine MBL. Validation studies have demonstrated that the results of the MP and AH method are well correlated, showing that the MP can measure MBL with sufficient accuracy. Additionally, the MP is more convenient for users, less expensive than the AH method, may be used in regions where the AH method is unavailable and may also be used as part of a digital application. Overall, the MP offers a convenient approach to monitor MBL both in research and clinical practice settings.

Citing Articles

Abnormal uterine bleeding: The well-known and the hidden face.

Leal C, Vannuccini S, Jain V, Dolmans M, Di Spiezio Sardo A, Al-Hendy A J Endometr Uterine Disord. 2024; 6.

PMID: 38764520 PMC: 11101194. DOI: 10.1016/j.jeud.2024.100071.


The Changes in Menstrual and Menstrual-Related Symptoms among Japanese Female University Students: A Prospective Cohort Study from Three Months to Nine Months after Admission.

Matsuura Y, Tran N, Yasui T Healthcare (Basel). 2023; 11(18).

PMID: 37761754 PMC: 10531057. DOI: 10.3390/healthcare11182557.


Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO Systems 1 and 2.

Jain V, Munro M, Critchley H Int J Gynaecol Obstet. 2023; 162 Suppl 2:29-42.

PMID: 37538019 PMC: 10952771. DOI: 10.1002/ijgo.14946.


Association between Patients' Self-Judgement, Coagulated Menstrual Blood, and Menorrhagia: Results from a Questionnaire Survey and Blood Test Analysis.

Lee E, Eun Ahn J, Ryu J, Jeong Y, Choi Y Medicina (Kaunas). 2023; 59(5).

PMID: 37241106 PMC: 10220994. DOI: 10.3390/medicina59050874.

References
1.
Cheong Y, Cameron I, Critchley H . Abnormal uterine bleeding. Br Med Bull. 2017; 123(1):103-114. DOI: 10.1093/bmb/ldx027. View

2.
Zakherah M, Sayed G, El-Nashar S, Shaaban M . Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin. Gynecol Obstet Invest. 2011; 71(4):281-4. DOI: 10.1159/000320336. View

3.
Stewart E, Nicholson W, Bradley L, Borah B . The burden of uterine fibroids for African-American women: results of a national survey. J Womens Health (Larchmt). 2013; 22(10):807-16. PMC: 3787340. DOI: 10.1089/jwh.2013.4334. View

4.
Schumacher U, Schumacher J, Mellinger U, Gerlinger C, Wienke A, Endrikat J . Estimation of menstrual blood loss volume based on menstrual diary and laboratory data. BMC Womens Health. 2012; 12:24. PMC: 3554478. DOI: 10.1186/1472-6874-12-24. View

5.
Haberland C, Filonenko A, Seitz C, Borner M, Gerlinger C, Doll H . Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies. J Patient Rep Outcomes. 2020; 4(1):97. PMC: 7666240. DOI: 10.1186/s41687-020-00263-0. View